Lumida
/TNGX
⌘K
Tango Therapeutics Inc

Tango Therapeutics Inc

TNGX
$28.56USD+3.33%+0.92 today

MARKET CAP

4.6B

P/E (TTM)

FWD P/E

DAY RANGE

$27 – $30

52W RANGE

$6
$34

AI Summary

Stalk
Sell NowMedium

In a Stage 4 decline, TNGX exhibits a clear sequence of lower highs and lower lows under bearish continuation patterns. Short-term weakness is confirmed by downtrending EMAs and failed rallies into resistance, making current conditions favorable to sell. Execution is recommended on rallies into the 9/21 EMA zone, where rejection at resistance can be anticipated.

  • Phase 2 data shows 92% ORR and 90% six-month PFS in PDAC
  • Analysts maintain 12 Buy ratings with a $41.50 average price target
  • Negative earnings yield and low book-to-price indicate overvaluation risk
Full analysis →
Insider Trades20 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jul 1, 2026SellTNGXAdam CrystalPresident, R&D54,000$17.39$4.6B-16.95%+394.97%$939.3K+0.00%10b5-1Stalk
Jun 1, 2026SellTNGXAdam CrystalPresident, R&D54,000$14.04$4.6B-16.95%+394.97%$758.0K+0.00%10b5-1Stalk
May 1, 2026SellTNGXAdam CrystalPresident, R&D54,000$13.21$4.6B-16.95%+394.97%$713.5K+0.00%10b5-1Stalk
Apr 15, 2026SellTNGXAdam CrystalPresident, R&D76,920$15.10$4.6B-16.95%+394.97%$1.2M+0.00%10b5-1Stalk
Apr 1, 2026SellTNGXAdam CrystalPresident, R&D54,000$13.20$4.6B-16.95%+394.97%$712.9K+0.00%10b5-1Stalk
Mar 25, 2026SellTNGXAdam CrystalPresident, R&D24,000$12.65$4.6B-16.95%+394.97%$303.7K+0.00%10b5-1Stalk
Mar 5, 2026SellTNGXAdam CrystalPresident, R&D20,251$15.00$4.6B-16.95%+394.97%$303.8K-15.24%10b5-1Stalk
Feb 25, 2026SellTNGXAdam CrystalPresident, R&D54,345$12.77$4.6B-16.95%+394.97%$694.2K-29.03%10b5-1Stalk
Feb 3, 2026SellTNGXDaniella BeckmanChief Financial Officer10,317$12.26$4.6B-16.95%+394.97%$126.5K-1.60%Stalk
Feb 3, 2026SellTNGXAdam CrystalPresident, R&D18,452$12.26$4.6B-16.95%+394.97%$226.3K-2.72%Stalk
Feb 3, 2026SellTNGXBarbara WeberDirector, Executive Chair30,519$12.26$4.6B-16.95%+394.97%$374.3K-0.87%Stalk
Feb 4, 2025SellTNGXDouglas BarryGeneral Counsel5,330$3.07$4.6B-16.95%+394.97%$16.4K-3.81%Stalk
Feb 4, 2025SellTNGXDaniella BeckmanChief Financial Officer8,232$3.07$4.6B-16.95%+394.97%$25.3K-2.63%Stalk
Feb 4, 2025SellTNGXAdam Crystal14,283$3.07$4.6B-16.95%+394.97%$43.9K-4.23%Stalk
Feb 4, 2025SellTNGXBarbara WeberChief Executive Officer18,791$3.07$4.6B-16.95%+394.97%$57.7K-0.57%Stalk
Feb 6, 2024SellTNGXDouglas BarryGeneral Counsel2,776$12.59$4.6B-16.95%+394.97%$35.0K-3.01%Stalk
Feb 6, 2024SellTNGXDaniella BeckmanChief Financial Officer3,725$12.59$4.6B-16.95%+394.97%$46.9K-1.38%Stalk
Feb 6, 2024SellTNGXAdam Crystal8,371$12.59$4.6B-16.95%+394.97%$105.4K-3.33%Stalk
Feb 6, 2024SellTNGXBarbara WeberChief Executive Officer9,138$12.59$4.6B-16.95%+394.97%$115.1K-0.30%Stalk
Nov 1, 2023SellTNGXAdam Crystal7,507$8.39$4.6B-16.95%+394.97%$63.0K-8.46%Stalk